Back

CD4 binding-site antibodies induced by a subtype B HIV-1 envelope trimer

Schorcht, A.; van den Kerkhof, T. L. G. M.; Torres, J.; Schermer, E.; LaBranche, C.; Bontjer, I.; Brinkkemper, M.; Gulzar, N.; Han, A. X.; Burger, J.; Ozorowski, G.; Scott, J.; Schuitemaker, H.; Montefiori, D.; van Gils, M.; Ward, A. B.; Sanders, R. W.

2022-03-25 immunology
10.1101/2022.03.23.485469 bioRxiv
Show abstract

In the last decade considerable advances have been made towards the design of HIV-1 vaccines that induce neutralizing antibodies (NAbs). Despite the progress, no vaccine is able to consistently elicited broadly neutralizing antibodies (bNAbs). Here we present a case study of a rabbit that was immunized with a subtype B native like envelope glycoprotein (Env) trimer, AMC016 SOSIP.v4.2, with a dense and intact glycan shield, followed by a trivalent combination of subtype B trimers. After the priming phase serum from this animal neutralized several heterologous subtype B neutralization resistant (tier 2) viruses. Subsequent immunization with the trivalent combination of subtype B trimers further increased the breadth and potency of the NAb response. EM based polyclonal epitope mapping revealed that a cross reactive CD4 binding-site (CD4bs) antibody response, that was present after priming with the monovalent trimer and boosting with the trivalent combination, was most likely responsible for the broad neutralization. While anecdotal, this study provides proof-of-concept that native-like Env trimers are capable of inducing CD4bs-directed bNAb responses and should guide efforts to improve the consistency with which such responses are generated.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.